Search for: "United States Patent & Trademark Office"
Results 21 - 40
of 6,229
Sort by Relevance
|
Sort by Date
30 May 2024, 12:10 pm
Tags: court cases, KSR, lawsuit, new patent, obtaining a patent, patent, patent application, patent attorney, patent infringement, patent lawyer, patent litigation, patent pending, patent process, patents, united states patent and trademark office, united states supreme court, USPTO Related posts It’s Hard Out Here for… [read post]
29 May 2024, 4:15 am
Therefore, the export control laws of the United States apply to patent prosecution. [read post]
29 May 2024, 4:15 am
Therefore, the export control laws of the United States apply to patent prosecution. [read post]
27 May 2024, 9:05 pm
Patent and Trademark Office (PTO) grants various types of patents for pharmaceutical companies. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
22 May 2024, 10:00 pm
In the recent decision Ex parte Chamberlain , Appeal 22-1944 ( Xencor ), the United States Patent and Trademark Office’s new Appeals Review Panel provided clarity regarding its stance on means-plus-function claims. [read post]
21 May 2024, 2:12 pm
The ApplicationOnce you are satisfied no one else has patented your invention, the next step is to draft and file a patent application with the United States Patent and Trademark Office (USPTO). [read post]
21 May 2024, 12:21 pm
Building upon the growing awareness of the pervasive use of generative AI, and its gradual adoption in the legal profession, the United States Patent and Trademark Office (USPTO) has taken steps to address the use of AI tools in practice before the agency. [read post]
21 May 2024, 12:21 pm
Building upon the growing awareness of the pervasive use of generative AI, and its gradual adoption in the legal profession, the United States Patent and Trademark Office (USPTO) has taken steps to address the use of AI tools in practice before the agency. [read post]
21 May 2024, 12:21 pm
Building upon the growing awareness of the pervasive use of generative AI, and its gradual adoption in the legal profession, the United States Patent and Trademark Office (USPTO) has taken steps to address the use of AI tools in practice before the agency. [read post]
21 May 2024, 10:07 am
In addition to his corporate practice, Scott is highly experienced in all aspects of trademark law, including clearance of proposed marks, prosecution of marks with the United States Patent and Trademark Office, and enforcement of trademark infringement claims. [read post]
20 May 2024, 4:25 pm
United States v. [read post]
20 May 2024, 2:15 pm
The United States Patent and Trademark Office (USPTO, the Office or the Agency) has recently issued multiple guidance and proposed rules that potentially change the landscape of patent practice. [read post]
20 May 2024, 11:15 am
The United States Patent and Trademark Office (USPTO, the Office or the Agency) has recently issued multiple guidance and proposed rules that potentially change the landscape of patent practice. [read post]
19 May 2024, 9:15 am
Senator Thom Tillis (R-NC) has been unsuccessfully trying to obtain information from the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO) on data being used to support drug pricing proposals for nearly two and a half years. [read post]
19 May 2024, 9:15 am
Senator Thom Tillis (R-NC) has been unsuccessfully trying to obtain information from the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO) on data being used to support drug pricing proposals for nearly two and a half years. [read post]